Literature DB >> 23018461

Transient enhanced IL-2R signaling early during priming rapidly amplifies development of functional CD8+ T effector-memory cells.

Iris Castro1, Michael J Dee, Thomas R Malek.   

Abstract

Much is known concerning the cellular and molecular basis for CD8(+) T memory immune responses. Nevertheless, conditions that selectively support memory generation have remained elusive. In this study, we show that an immunization regimen that delivers TCR signals through a defined antigenic peptide, inflammatory signals through LPS, and growth and differentiation signals through the IL-2R initially favors Ag-specific CD8(+) T cells to develop rapidly and substantially into T effector-memory cells by TCR transgenic OVA-specific OT-I CD8(+) T cells. Amplified CD8(+) T memory development depends upon a critical frequency of Ag-specific T cells and direct responsiveness to IL-2. A homologous prime-boost immunization protocol with transiently enhanced IL-2R signaling in normal mice led to persistent polyclonal Ag-specific CD8(+) T cells that supported protective immunity to Listeria monocytogenes. These results identify a general approach for amplified T memory development that may be useful to optimize vaccines aimed at generating robust cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018461      PMCID: PMC3478487          DOI: 10.4049/jimmunol.1202067

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Initial antigen encounter programs CD8+ T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment.

Authors:  Roberto Carrio; Oliver F Bathe; Thomas R Malek
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

2.  CD8+ T cell contraction is controlled by early inflammation.

Authors:  Vladimir P Badovinac; Brandon B Porter; John T Harty
Journal:  Nat Immunol       Date:  2004-07-11       Impact factor: 25.606

3.  A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets.

Authors:  Christian Stemberger; Katharina M Huster; Martina Koffler; Florian Anderl; Matthias Schiemann; Hermann Wagner; Dirk H Busch
Journal:  Immunity       Date:  2007-12       Impact factor: 31.745

4.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

5.  Signal integration by Akt regulates CD8 T cell effector and memory differentiation.

Authors:  Eui Ho Kim; Jeremy A Sullivan; Erin H Plisch; Melba Marie Tejera; Anna Jatzek; Kwan Yong Choi; M Suresh
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

6.  Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.

Authors:  Jun Chang; So Young Choi; Hyun Tak Jin; Young Chul Sung; Thomas J Braciale
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

Review 7.  Immune responses to Listeria monocytogenes.

Authors:  Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

8.  Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2).

Authors:  Christophe L Nguyen; Mohamed L Salem; Mark P Rubinstein; Marina Demcheva; John N Vournakis; David J Cole; William E Gillanders
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

9.  Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo.

Authors:  Joseph N Blattman; Jason M Grayson; E John Wherry; Susan M Kaech; Kendall A Smith; Rafi Ahmed
Journal:  Nat Med       Date:  2003-04-14       Impact factor: 53.440

10.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

View more
  11 in total

1.  Manipulating Memory CD8 T Cell Numbers by Timed Enhancement of IL-2 Signals.

Authors:  Marie T Kim; Samarchith P Kurup; Gabriel R Starbeck-Miller; John T Harty
Journal:  J Immunol       Date:  2016-07-20       Impact factor: 5.422

2.  Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.

Authors:  Robert G Newman; Michael J Dee; Thomas R Malek; Eckhard R Podack; Robert B Levy
Journal:  Blood       Date:  2014-03-31       Impact factor: 22.113

3.  An Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis.

Authors:  Xuqing Zhang; Michael N Starnbach
Journal:  J Immunol       Date:  2015-07-15       Impact factor: 5.422

Review 4.  Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.

Authors:  Denise Skrombolas; John G Frelinger
Journal:  Expert Rev Clin Immunol       Date:  2014-02       Impact factor: 4.473

5.  CD122 signaling in CD8+ memory T cells drives costimulation-independent rejection.

Authors:  David V Mathews; Ying Dong; Laura B Higginbotham; Steven C Kim; Cynthia P Breeden; Elizabeth A Stobert; Joseph Jenkins; J Yun Tso; Christian P Larsen; Andrew B Adams
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

Review 6.  The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.

Authors:  Robert G Newman; Duncan B Ross; Henry Barreras; Samantha Herretes; Eckhard R Podack; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

7.  Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms.

Authors:  Jamie B Spangler; Jakub Tomala; Vincent C Luca; Kevin M Jude; Shen Dong; Aaron M Ring; Petra Votavova; Marion Pepper; Marek Kovar; K Christopher Garcia
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

8.  Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity.

Authors:  Rosmely Hernandez; Kevin H Toomer; Janika Põder; Alicia Santos Savio; Sunnie Hsiung; Thomas R Malek
Journal:  Cancer Immunol Immunother       Date:  2020-10-10       Impact factor: 6.968

9.  Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions.

Authors:  Mithun Khattar; Yoshihiro Miyahara; Paul M Schroder; Aini Xie; Wenhao Chen; Stanislaw M Stepkowski
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

10.  Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells.

Authors:  Anna Śledzińska; Maria Vila de Mucha; Katharina Bergerhoff; Alastair Hotblack; Dafne Franz Demane; Ehsan Ghorani; Ayse U Akarca; Maria A V Marzolini; Isabelle Solomon; Frederick Arce Vargas; Martin Pule; Masahiro Ono; Benedict Seddon; George Kassiotis; Charlotte E Ariyan; Thomas Korn; Teresa Marafioti; Graham M Lord; Hans Stauss; Richard G Jenner; Karl S Peggs; Sergio A Quezada
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.